Evidence map›Paper›PMID 33844128›Full record

ArticleClinical journal of gastroenterology2021

A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy.

Miha Orazem, Cédric Draulans, Mathieu Spaas, Eric Van Cutsem, Marina Debecker, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans

Open access · greenAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Miha Orazem *Department of Oncology, KU Leuven, Leuven, Belgium.
Cédric Draulans *Department of Oncology, KU Leuven, Leuven, Belgium. cedric.draulans@uzleuven.be.ORCID http://orcid.org/0000-0002-1267-7874
Mathieu SpaasDepartment of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium.
Eric Van CutsemDepartment of Oncology, KU Leuven, Leuven, Belgium.
Marina DebeckerDepartment of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Gert De MeerleerDepartment of Oncology, KU Leuven, Leuven, Belgium.
Sabine TejparDepartment of Oncology, KU Leuven, Leuven, Belgium.
Jeroen Dekervel *Department of Oncology, KU Leuven, Leuven, Belgium.
Karin Haustermans *Department of Oncology, KU Leuven, Leuven, Belgium. karin.haustermans@uzleuven.be.
KU Leuven · BEInstitute of Oncology Ljubljana · SIEurope Hospitals · BEGhent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMultimodality treatments combining radiotherapy, immune therapy and/or targeted therapy are under heavy investigation. Promising data from clinical trials are emerging, nevertheless unexpected interactions and adverse events should not be overlooked. CASE PRESENTATION: Here we present a case study of a patient with metastatic colon adenocarcinoma treated sequentially with a chemotherapy/targeted therapy combination, immune checkpoint inhibitors and ultra-hypofractionated radiotherapy. After radiation treatment, the patient developed extensive posterior abdominal wall wounds coinciding with regression of the irradiated metastatic tumour mass and marked elevation of the inflammation parameters.

conclusionThis case represents an unusual fatal wound complication after palliative ultra-hypofractionated radiotherapy. Further research into synergistic effects of sequential radiotherapy and anti-angiogenesis therapy may provide an advantage in anticipating severe sequelae.

Indexed as

Immune Checkpoint InhibitorsImmunotherapyCombined Modality TherapyHumansImmune Checkpoint InhibitorsAnti-angiogenesisCase reportComplicationImmune checkpoint inhibitionRadiotherapy

Identifiers

PMID33844128
OpenAlexW3152955790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.